Barclays lowered the firm’s price target on Intuitive Surgical (ISRG) to $651 from $712 and keeps an Overweight rating on the shares post the Q1 report. The company reported a “strong fundamental beat” driven by procedures and system sales, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical Earnings Call Signals Robust Growth
- Early notable gainers among liquid option names on April 22nd
- Video: Boeing rises after better than expected Q1 results
- Intuitive Surgical: Strong Q1 Execution, Rising DV5 Utilization, and Manageable International Headwinds Support Buy Rating
- Intuitive Surgical price target raised to $610 from $575 at Baird